SCHEMBL19200033

SCHEMBL19200033

CC(C)O[C@H]1O[C@@H](C(=O)O)C[C@@H](O)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6932983 0.88 — —
SCHEMBL10258933 0.85 PPM1B (0.33) —
SCHEMBL17267039 0.80 LGALS8 (0.36) —
SCHEMBL24212703 0.80 LGALS8 (0.36) —
SCHEMBL22828540 0.80 LGALS8 (0.36) —
SCHEMBL20131876 0.79 RAB9A (0.31) —
SCHEMBL21134683 0.77 — —
SCHEMBL14505187 0.77 — —
SCHEMBL21765949 0.76 — —
SCHEMBL22828158 0.76 TK1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892305-A1 HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY Sutro Biopharma, Inc. (US) 2021-10-13 — — EP disclosed
EP-3250237-B1 HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY SUTRO BIOPHARMA INC (US) 2021-05-26 — — EP disclosed
WO-2020252043-A1 5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF SUTRO BIOPHARMA, INC. (US) 2020-12-17 — — WO disclosed
WO-2020252015-A1 IMMUNOMODULATOR ANTIBODY DRUG CONJUGATES AND USES THEREOF SUTRO BIOPHARMA, INC. (US) 2020-12-17 — — WO disclosed
WO-2019055909-A1 ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES SUTRO BIOPHARMA, INC. (US) 2019-03-21 — — WO disclosed
WO-2019055931-A1 ANTI- FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES SUTRO BIOPHARMA, INC. (US) 2019-03-21 — — WO disclosed
WO-2017132617-A1 ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES SUTRO BIOPHARMA, INC. (US) 2017-08-03 — — WO disclosed
Send feedback